SFG Wealth Management LLC. Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SFG Wealth Management LLC. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 407 shares of the medical equipment provider’s stock, valued at approximately $212,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. UMB Bank n.a. raised its position in Intuitive Surgical by 0.8% in the 4th quarter. UMB Bank n.a. now owns 37,242 shares of the medical equipment provider’s stock valued at $19,439,000 after buying an additional 309 shares during the last quarter. Wealth Management Partners LLC raised its holdings in shares of Intuitive Surgical by 4.0% in the fourth quarter. Wealth Management Partners LLC now owns 2,059 shares of the medical equipment provider’s stock valued at $1,075,000 after purchasing an additional 80 shares during the last quarter. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter worth about $82,517,000. Finally, Diversify Advisory Services LLC grew its position in Intuitive Surgical by 42.4% in the 4th quarter. Diversify Advisory Services LLC now owns 7,227 shares of the medical equipment provider’s stock worth $3,957,000 after purchasing an additional 2,151 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James boosted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Activity

In other news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. The trade was a 88.63 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $592.64 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The stock has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The stock has a fifty day moving average of $540.66 and a 200-day moving average of $499.19.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.